To accomplish this objective, his group develops: (A) molecular technologies that write cellular experiences to their genomic DNA, (B) sequencing strategies that read out written information with high cellular and spatial resolution, and (C) computational methods that reconstruct the underlying biological processes based on recorded information. Their work draws on genomics, molecular engineering, CRISPR-based genome editing, and computational approaches to address brain development, developmental anomalies, and cancer.